Data gathering
- Red flags
- Others
- lump – first noticed, changed in size, armpits
- breast – pain
- nipple – changes, discharge
- menstrual history
- FH
- Risk factors – never had a child, never breastfed, early menarche, late menopause, HRT, alcohol
- Examine
- Inspect – sitting, hands behind head
- breast symmetry
- nipple changes
- skin changes – dimpling, redness, oedema
- Palpation – hand above head
- breast – vertical strip method
- axilla
- supraclavicular and cervical LN
Clinical management
- the following should be referred via two week wait:
- a discrete, hard lump with fixation, with or without skin tethering
- >30 year old + discrete lump that persists after their next period or presents after menopause
- persistent focal area of lumpiness or focal change in breast texture
- previous breast cancer, who present with a further lump or suspicious symptoms.
- Women with skin distortion or signs of oedema in the skin.
- Women with unilateral eczematous skin or nipple change that does not respond to topical treatment.
- Women with nipple distortion of recent onset.
- Women with spontaneous unilateral bloody nipple discharge.
- Women with persistent unexplained axillary swelling.
- Men aged 50 years and older with a unilateral, firm subareolar mass, with or without nipple distortion, or associated skin changes.
- Women aged younger than 30 years who present:
- With a lump that enlarges.
- With a lump and other reasons for concern, such as family history.
- The following should be referred and seen routinely:
- Women aged younger than 30 years with a lump without sinister features or other concerns.
- Women under 50 years who have nipple discharge that is from multiple ducts or
is intermittent and is neither bloodstained nor troublesome
- Women with breast pain and no palpable abnormality, when initial treatment fails and/or with unexplained persistent symptoms.
NB: lump should be described by location, size, mobility, texture
Breast cancer family history
- Red flags
- Family tree
- Age of diagnosis
- Bilateral
- Male
- Ovarian, prostate cancer
- Ashkenazi Jew
- Treatment
- Breast aware – self checks, attending screening
- Lifestyle – weight loss, exercise, reduce alcohol and smoking
- Medications – stop COCP, HRT
- Follow-up / Safety-net
- Refer to genetics clinic for counselling – if moderate risk